Harmony Biosciences Holdings (HRMY) Debt Ratio (2019 - 2026)

Harmony Biosciences Holdings has disclosed Debt Ratio across 8 years of filings, most recently posting 0.12 for Q1 2026.

• Debt Ratio for Q1 2026 came in at 0.12, down 24.97% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.12 (down 24.97% YoY), and the FY2025 annual result was 0.13, down 28.26% from the prior year.
• Debt Ratio came in at 0.12 for Q1 2026 at Harmony Biosciences Holdings, down from 0.13 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.41 in Q1 2022 to a low of 0.12 in Q1 2026.
• The 5-year median for Debt Ratio is 0.22 (2024), against an average of 0.23.
• Across the five-year window, Debt Ratio slumped 39.33% in 2022 and fell 13.78% in 2024, its largest moves.
• Harmony Biosciences Holdings' Debt Ratio stood at 0.28 in 2022, then declined by 16.12% to 0.24 in 2023, then fell by 24.79% to 0.18 in 2024, then dropped by 28.26% to 0.13 in 2025, then retreated by 2.98% to 0.12 in 2026.
• The last three Debt Ratio figures came in at 0.12 (Q1 2026), 0.13 (Q4 2025), and 0.14 (Q3 2025), per Business Quant data.